Specialty drug delivery technologies


A pharmaceutical CDMO you can trust

First time in man acceleration

A CDMO that will earn your confidence.

A scientist to lead your project, full analytical support to keep it on track, and a veteran team to complete it successfully. That’s the Metrics promise.

$65 Million Expansion & Renovation

Expanded formulation development, analytical laboratory and CTM capabilities make way for a ‘Concept to Commercialization’ solution for clients.

Expertise and Industry Experience

Our scientists offer insight on current trends and technologies through published articles, posters and white papers.

Accelerated FTIM timeline?
No problem.

Having successfully completed more than 130 fast-track studies, Metrics has a solid reputation for meeting FTIM and Phase I deadlines.

See how we keep your project flowing smoothly.

Our experienced scientists bring a wealth of knowledge to your biggest drug development challenges. They also bring something else: leadership.

Learn more.

Small molecule expertise with a big emphasis on service.

When it comes to pharmaceutical development, few CDMOs can match the depth of expertise and experience you’ll find here.

Learn more.

Meet the teams that keep things moving.

When you bring your development project to us, you’re bringing it to a finely-tuned team of scientists and technicians committed to delivering quality, on-time results.

Learn more.

Mayne Pharma to Invest $65M in Major Manufacturing Expansion in North Carolina

The company will invest $65 million to significantly expand facilities and equipment at its site in Greenville, N.C. Plans include greenfield construction of a new, 126,000-square-foot oral-dose commercial manufacturing facility, doubling U.S. manufacturing capacity, plus repurposing of existing space to expand contract services.

Learn more

Sample Submission Form

Sending a sample to Metrics?
Use this form to record your sample, storage and testing information.


Technology Transfer from a CDMO Perspective

Metrics Contract Services outlines two case studies of different drug sponsors engaging a CDMO with development.

Learn more

Metrics Contract Services Expands Analytical Lab Capabilities With Additional UPLC Equipment

The company’s investment in leading liquid chromatography technologies will provide additional capability in services clients are seeking.

Learn more

Metrics Contract Services Appoints New Vice President of Analytical Services

Providing strategic oversight to a team of 100+ chemists, Keith Moore will support Metrics Contract Services with its rapidly growing client base and ever-evolving international quality compliance regulations.

Learn more

Metrics a Founding Member of PBOA

Metrics Contract Services is proud to be a founding member of the Pharma and Biopharma Outsourcing Association, an association of pharma and biopharma contract development and manufacturing organizations (CDMOs) working collaboratively to advocate for our industry.  

Learn more

Metrics Invests in New Equipment

Already known and respected for its analytical capabilities, Metrics has purchased new equipment that will speed testing for elemental impurities per new international USP guidelines.

Learn more

Charged Aerosol Detection

Metrics Contract Services has significant experience utilizing CAD technology throughout the drug development process. Let us help with your next project.

Learn more

Metrics Scientist Awarded Patent

Dr. Brad Gold, vice president of pharmaceutical development, has received a U.S. patent for his intellectual property about controlled release technology. The U.S. Patent and Trademark Office awarded Gold a patent (No. 8,858,993) for his application, “Coated tablets with zero-order or near zero-order release kinetics.”

Learn more

Metrics Inc. Expands with Fast-Track Product Development Laboratory

Along with Gerteis Mini-Pactor®, capital investments reflect ongoing commitment to contract services

Learn more